Organon(OGN)
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon sells to international markets.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
Mock data
Subscribe for the real data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name | Drug Name | Approved | Patent Expires | Indication |
|---|---|---|---|---|
| Adrovance | Alendronic acid, Colecalciferol | 2007-01-04 | 2031 | |
| Aerinaze | Desloratadine, Pseudoephedrine | 2007-07-30 | ||
| Aerius | Desloratadine | 2001-01-15 | ||
| Arduan | Pipecuronium | 1990-06-26 | — | |
| Asmanex | Mometasone furoate | 2005-03-30 | — | |
| Azomyr | Desloratadine | 2001-01-15 | ||
| Calderol | Calcifediol | 1982-01-01 | 2027-2034 | — |
| Celestone soluspan | Betamethasone | 1982-01-01 | 2027-2039 | |
| Clarinex | Desloratadine, Pseudoephedrine | 2001-12-21 | ||
| Clarinex d | Desloratadine, Pseudoephedrine | 2005-03-03 | ||
| Cotazym | Pancrelipase | 1996-12-09 | — | |
| Cozaar | Losartan potassium | 1995-04-14 | — |
1
2
3
4
5
>
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Indication |
|---|---|---|---|---|---|
1
2
3
4
5
6
...
9
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use